Left-ventricular innervation assessed by


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 04 01 2020
revised: 15 02 2020
accepted: 04 03 2020
pubmed: 24 3 2020
medline: 15 5 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

Impaired myocardial sympathetic innervation assessed by We assessed ventricular sympathetic innervation (LV, RV and planar heart/mediastinum-ratios, and washout-rates) by We demonstrated that chamber-specific

Identifiants

pubmed: 32201099
pii: S0167-5273(19)36249-7
doi: 10.1016/j.ijcard.2020.03.013
pii:
doi:

Substances chimiques

Iodine Radioisotopes 0
Radiopharmaceuticals 0
3-Iodobenzylguanidine 35MRW7B4AD
Iodine-123 8YWR746RPQ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-135

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors has a conflict of interest to declare associated with this manuscript.

Auteurs

Johannes Siebermair (J)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany; Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; German Cardiovascular Research Center (DZHK), Munich Heart Alliance, Munich, Germany.

Sebastian Lehner (S)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Ambulatory Healthcare Center Dr. Neumaier & Colleagues, Radiology, Nuclear Medicine, Radiation Therapy, Regensburg, Germany.

Stefan M Sattler (SM)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; Department of Cardiology, Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Konstantinos D Rizas (KD)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany.

Britt-Maria Beckmann (BM)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany.

Alexander Becker (A)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany.

Julia Schiller (J)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany.

Corona Metz (C)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany.

Mathias Zacherl (M)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Nadine Vonderlin (N)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany; Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; German Cardiovascular Research Center (DZHK), Munich Heart Alliance, Munich, Germany.

Tienush Rassaf (T)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.

Dobromir Dobrev (D)

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.

Christoph Rischpler (C)

Clinic for Nuclear Medicine, University Hospital Essen, Essen, Germany.

Stefan Kääb (S)

Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; German Cardiovascular Research Center (DZHK), Munich Heart Alliance, Munich, Germany.

Marcus Hacker (M)

Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Vienna, Austria. Electronic address: Marcus.Hacker@meduniwien.ac.at.

Andrei Todica (A)

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Reza Wakili (R)

Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany; Department of Medicine I, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; German Cardiovascular Research Center (DZHK), Munich Heart Alliance, Munich, Germany. Electronic address: reza.wakili@uk-essen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH